Tenon Medical Inc (TNON) — Defensive Interval Ratio

Latest as of March 2026: 97 days

Tenon Medical Inc (TNON) has a Defensive Interval Ratio of 97 days as of March 2026. Defensive assets of $1.97 Million (cash $-, short-term investments $-, receivables $1.97 Million) cover 97 days of daily cash needs of $20.29K/day. See Tenon Medical Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

Defensive Interval Ratio

97 days
Days of operational coverage

Defensive Assets

$1.97 Million
Cash + ST Investments + Receivables

Daily Cash Need

$20.29K
Current Liabilities ÷ 365

Current Liabilities

$7.41 Million
USD

Tenon Medical Inc Defensive Interval Ratio (2019–2025)

This chart shows how Tenon Medical Inc's Defensive Interval Ratio has evolved across 7 annual periods from 2019 to 2025. As of March 2026, the ratio stands at 97 days, meaning defensive assets of $1.97 Million can fund 97 days of operations without new revenue. See Tenon Medical Inc (TNON) net asset quality to measure how much of total assets are equity-financed.

Annual Defensive Interval Ratio for Tenon Medical Inc (2019–2025)

The table below presents the year-by-year Defensive Interval Ratio for Tenon Medical Inc from 2019 to 2025, covering 7 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see TNON company net worth.

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
2025 193 days $1.70 Million $8.80K/day $- $- ▲ +24 days
2024 169 days $863.00K $5.12K/day $- $- ▲ +107 days
2023 61 days $526.00K $8.60K/day $- $0.00 ▼ -903 days
2022 964 days $6.68 Million $6.93K/day $- $6.44 Million ▲ +857 days
2021 107 days $4.48 Million $41.85K/day $- $4.40 Million ▲ +104 days
2020 4 days $14.47K $4.09K/day $- $0.00 ▼ -8 days
2019 12 days $53.77K $4.63K/day $- $-
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)